395 related articles for article (PubMed ID: 24328060)
1. Flavonoids as therapeutic compounds targeting key proteins involved in Alzheimer's disease.
Baptista FI; Henriques AG; Silva AM; Wiltfang J; da Cruz e Silva OA
ACS Chem Neurosci; 2014 Feb; 5(2):83-92. PubMed ID: 24328060
[TBL] [Abstract][Full Text] [Related]
2. Molecular Insight into the Therapeutic Promise of Flavonoids against Alzheimer's Disease.
Uddin MS; Kabir MT; Niaz K; Jeandet P; Clément C; Mathew B; Rauf A; Rengasamy KRR; Sobarzo-Sánchez E; Ashraf GM; Aleya L
Molecules; 2020 Mar; 25(6):. PubMed ID: 32168835
[TBL] [Abstract][Full Text] [Related]
3. Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease.
Rockenstein E; Torrance M; Mante M; Adame A; Paulino A; Rose JB; Crews L; Moessler H; Masliah E
J Neurosci Res; 2006 May; 83(7):1252-61. PubMed ID: 16511867
[TBL] [Abstract][Full Text] [Related]
4. Flavonoids, cognition, and dementia: actions, mechanisms, and potential therapeutic utility for Alzheimer disease.
Williams RJ; Spencer JP
Free Radic Biol Med; 2012 Jan; 52(1):35-45. PubMed ID: 21982844
[TBL] [Abstract][Full Text] [Related]
5. Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells.
Lovestone S; Reynolds CH; Latimer D; Davis DR; Anderton BH; Gallo JM; Hanger D; Mulot S; Marquardt B; Stabel S
Curr Biol; 1994 Dec; 4(12):1077-86. PubMed ID: 7704571
[TBL] [Abstract][Full Text] [Related]
6. FLZ alleviates the memory deficits in transgenic mouse model of Alzheimer's disease via decreasing beta-amyloid production and tau hyperphosphorylation.
Bao XQ; Li N; Wang T; Kong XC; Tai WJ; Sun H; Zhang D
PLoS One; 2013; 8(11):e78033. PubMed ID: 24223757
[TBL] [Abstract][Full Text] [Related]
7. Protective effects of flavonoids against Alzheimer's disease-related neural dysfunctions.
Bakhtiari M; Panahi Y; Ameli J; Darvishi B
Biomed Pharmacother; 2017 Sep; 93():218-229. PubMed ID: 28641164
[TBL] [Abstract][Full Text] [Related]
8. Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease.
Ho L; Qin W; Pompl PN; Xiang Z; Wang J; Zhao Z; Peng Y; Cambareri G; Rocher A; Mobbs CV; Hof PR; Pasinetti GM
FASEB J; 2004 May; 18(7):902-4. PubMed ID: 15033922
[TBL] [Abstract][Full Text] [Related]
9. Melatonin ameliorates Aβ
Chinchalongporn V; Shukla M; Govitrapong P
J Pineal Res; 2018 May; 64(4):e12470. PubMed ID: 29352484
[TBL] [Abstract][Full Text] [Related]
10. Huperzine A regulates amyloid precursor protein processing via protein kinase C and mitogen-activated protein kinase pathways in neuroblastoma SK-N-SH cells over-expressing wild type human amyloid precursor protein 695.
Peng Y; Lee DY; Jiang L; Ma Z; Schachter SC; Lemere CA
Neuroscience; 2007 Dec; 150(2):386-95. PubMed ID: 17945434
[TBL] [Abstract][Full Text] [Related]
11. The Streptomyces metabolite anhydroexfoliamycin ameliorates hallmarks of Alzheimer's disease in vitro and in vivo.
Leirós M; Alonso E; Rateb ME; Ebel R; Jaspars M; Alfonso A; Botana LM
Neuroscience; 2015 Oct; 305():26-35. PubMed ID: 26247694
[TBL] [Abstract][Full Text] [Related]
12. Dishevelled regulates the metabolism of amyloid precursor protein via protein kinase C/mitogen-activated protein kinase and c-Jun terminal kinase.
Mudher A; Chapman S; Richardson J; Asuni A; Gibb G; Pollard C; Killick R; Iqbal T; Raymond L; Varndell I; Sheppard P; Makoff A; Gower E; Soden PE; Lewis P; Murphy M; Golde TE; Rupniak HT; Anderton BH; Lovestone S
J Neurosci; 2001 Jul; 21(14):4987-95. PubMed ID: 11438574
[TBL] [Abstract][Full Text] [Related]
13. Tau therapeutic strategies for the treatment of Alzheimer's disease.
Churcher I
Curr Top Med Chem; 2006; 6(6):579-95. PubMed ID: 16712493
[TBL] [Abstract][Full Text] [Related]
14. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
Padmanabhan J; Levy M; Dickson DW; Potter H
Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
[TBL] [Abstract][Full Text] [Related]
15. The γ-secretase modulator CHF5074 reduces the accumulation of native hyperphosphorylated tau in a transgenic mouse model of Alzheimer's disease.
Lanzillotta A; Sarnico I; Benarese M; Branca C; Baiguera C; Hutter-Paier B; Windisch M; Spano P; Imbimbo BP; Pizzi M
J Mol Neurosci; 2011 Sep; 45(1):22-31. PubMed ID: 21181298
[TBL] [Abstract][Full Text] [Related]
16. Interplay between cyclin-dependent kinase 5 and glycogen synthase kinase 3 beta mediated by neuregulin signaling leads to differential effects on tau phosphorylation and amyloid precursor protein processing.
Wen Y; Planel E; Herman M; Figueroa HY; Wang L; Liu L; Lau LF; Yu WH; Duff KE
J Neurosci; 2008 Mar; 28(10):2624-32. PubMed ID: 18322105
[TBL] [Abstract][Full Text] [Related]
17. Caspase-3-dependent cleavage of Akt modulates tau phosphorylation via GSK3β kinase: implications for Alzheimer's disease.
Chu J; Lauretti E; Praticò D
Mol Psychiatry; 2017 Jul; 22(7):1002-1008. PubMed ID: 28138159
[TBL] [Abstract][Full Text] [Related]
18. Akt/GSK3beta serine/threonine kinases: evidence for a signalling pathway mediated by familial Alzheimer's disease mutations.
Ryder J; Su Y; Ni B
Cell Signal; 2004 Feb; 16(2):187-200. PubMed ID: 14636889
[TBL] [Abstract][Full Text] [Related]
19. New therapeutic approaches in Alzheimer's disease.
Barcikowska M
Folia Neuropathol; 2004; 42(4):251-5. PubMed ID: 15679044
[TBL] [Abstract][Full Text] [Related]
20. Alzheimer-like amyloid and tau alterations associated with cognitive deficit in temporal lobe epilepsy.
Gourmaud S; Shou H; Irwin DJ; Sansalone K; Jacobs LM; Lucas TH; Marsh ED; Davis KA; Jensen FE; Talos DM
Brain; 2020 Jan; 143(1):191-209. PubMed ID: 31834353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
